These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4265077)

  • 1. [Metabolic complications of obesity--attempt to influence them by dehydroepiandrosterone sulfate].
    Simonová J; Gregorová I; Sonka J
    Sb Lek; 1973 Jan; 75(1):27-32. PubMed ID: 4265077
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dehydroepiandrosterone and its conjugates upon the activity of glucose-6-phosphate dehydrogenase. 3. Inhibition of glucose-6-phosphate dehydrogenase in human ovarian tissue.
    Oertel GW; Menzel P; Bauke D
    Steroidologia; 1970; 1(1):2-7. PubMed ID: 4398584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Menopause and metabolic disorders].
    Sonka J; Gregorová I; Kölbel F
    Cesk Gynekol; 1965 Aug; 30(6):456-62. PubMed ID: 4220844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of glucose-6-phosphate dehydrogenase in human brain tissue. VI. Effect of androstenolone and its conjugates on the activity of glucose-6-phosphate dehydrogenase].
    Menzel E; Menzel P; Oertel GW
    Hoppe Seylers Z Physiol Chem; 1970 Jun; 351(6):759-60. PubMed ID: 4393250
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dehydroepiandrosterone and its conjugates upon the activity of glucose-6-phosphate dehydrogenase in human erythrocytes.
    Oertel GW; Rebelein I
    Biochim Biophys Acta; 1969 Jul; 184(2):459-60. PubMed ID: 4241337
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of psoriasis using dehydroepiandrosterone-enanthate].
    Holzmann H; Morsches B; Krapp R; Hoffmann G; Oertel GW
    Z Haut Geschlechtskr; 1972 Feb; 47(3):99-110. PubMed ID: 4259836
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of steroids on glucose-6-phosphate dehydrogenase and lipid metabolism].
    Oertel GW
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:46-52. PubMed ID: 4261453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of glucose-6-phosphate dehydrogenase by steroids. 7. Influence of placental G-6-PDH activity on estrogen synthesis from 7-alpha-3H-DHEA, 7-alpha-3H-DHEA sulfate or 7-alpha-3H-DHEA sulfatide].
    Hoffmann G; Badens D; Kreuzer A; Oertel GW
    Endokrinologie; 1973 Jan; 61(1):124-31. PubMed ID: 4267203
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma lipids and steroid hormones in patients with hypercholesterolaemia or hyperlipaemia during dehydroepiandrosterone sulphate administration.
    Adlercreutz H; Kerstell J; Schaumann KO; Svanborg A; Vihko R
    Eur J Clin Invest; 1972 Jan; 2(2):91-5. PubMed ID: 4260355
    [No Abstract]   [Full Text] [Related]  

  • 10. Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent.
    Schwartz AG; Hard GC; Pashko LL; Abou-Gharbia M; Swern D
    Nutr Cancer; 1981; 3(1):46-53. PubMed ID: 6213940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroids and skin. V. Plasma dehydroepiandrosterone and erythrocyte glucose-6-phosphate dehydrogenase activity in psoriatic patients before and after the administration of dehydroepiandrosterone sulfate].
    Oertel GW; Menzel P; Hoffmann G; Holzmann H; Morsches B; Gebhardt R
    Z Klin Chem Klin Biochem; 1971 Jan; 9(1):28-30. PubMed ID: 4252824
    [No Abstract]   [Full Text] [Related]  

  • 12. Gout and dehydroepiandrosterone. 3. DHEA administration.
    Sonka J; Krizek V; Gregorová I; Staś J
    Endokrynol Pol; 1973; 24(3):209-18. PubMed ID: 4269439
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.
    Tchernof A; Labrie F; Bélanger A; Després JP
    J Endocrinol; 1996 Sep; 150 Suppl():S155-64. PubMed ID: 8943799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of DHA in the pathogenesis of obesity and its metabolic complications.
    Sonka J; Gregorovà I
    Pol Arch Med Wewn; 1969; 42(3):549-51. PubMed ID: 4389291
    [No Abstract]   [Full Text] [Related]  

  • 15. Dehydroepiandrosterone. Metabolic effects.
    Sonka J
    Acta Univ Carol Med Monogr; 1976; 71():1-137, 146-71. PubMed ID: 136178
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic changes in survivors of myocardial infarct].
    Salazar E; Luis Moragrega J; Magos C; Zorrilla E; Serrano PA
    Arch Inst Cardiol Mex; 1973; 43(1):4-17. PubMed ID: 4696405
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of dehydroepiandrosterone on the activity of glucose-6-phosphate-dehydrogenase and on the growth of the Ehrlich ascitic tumor (author's transl)].
    Avenariová I; Schwartz E
    Bratisl Lek Listy; 1975 Dec; 64(6):698-703. PubMed ID: 127649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Steroids and the skin. 8. In vitro experiments with 7 - 3 H-dehydroepiandrosterone and its sulfoconjugates on intact erythrocytes in psoriasis vulgaris].
    Hoffmann G; Morsches B; Döhler U; Holzmann H; Oertel GW
    Arch Dermatol Forsch; 1972; 243(1):18-30. PubMed ID: 4261362
    [No Abstract]   [Full Text] [Related]  

  • 20. A possible interrelation between glucose-6-phosphate dehydrogenase and dehydroepiandrosterone in obesity.
    Lopez A; Krehl WA
    Lancet; 1967 Sep; 2(7514):485-7. PubMed ID: 4166407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.